Dioctan etynodiolu + etynyloestradiol: interakcje

Dioctan etynodiolu + etynyloestradiol (Zovia, Kelnor, Valtya), doustny środek antykoncepcyjny: 218 udokumentowanych interakcji w indeksowanych przez nas etykietach FDA i kartach informacyjnych. Poważne: 30, umiarkowane: 122, niewielkie: 50, pary, dla których etykieta nie zgłasza istotnej interakcji: 16. Każda pozycja poniżej cytuje zdanie, na którym się opiera. Ta strona leku to punkt wyjścia, a nie rozstrzygnięcie dla indywidualnej sytuacji.

Interakcje z etykiety

Poważne interakcje (30)

  • AcytretynaretinoidPoważna

    For patients with amenorrhea, the second test should be done at least 11 days after the last act of unprotected sexual intercourse (without using 2 effective forms of contraception [birth control] simultaneously). (etykieta leku Acytretyna, Ostrzeżenie w ramce)

  • Anastrozolinhibitor aromatazyPoważna

    Estrogen Estrogen-containing therapies should not be used with ARIMIDEX as they may diminish its pharmacological action. (etykieta leku Anastrozol, Interakcje z innymi lekami)

  • Dezogestrel + etynyloestradioldoustny środek antykoncepcyjnyPoważna

    …surgery with prolonged immobilization • Current diagnosis of, or history of, breast cancer, which may be hormone-sensitive • Carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia • Undiagnosed abnormal genital bleeding • Cholestatic jaundice of pregnancy or jaundice with prior pill use • Acute or chronic hepatocellular disease with… (etykieta leku Dezogestrel + etynyloestradiol, Przeciwwskazania)

  • DziurawiecZioła i suplementyPoważna

    Dziurawiec może zmniejszać skuteczność tabletek antykoncepcyjnych. (NCCIH, St. John's Wort)

  • Eksemestaninhibitor aromatazyPoważna

    Administration with Estrogen-Containing Agents EXEMESTANE should not be coadministered with systemic estrogen-containing agents as these could interfere with its pharmacologic action. (etykieta leku Eksemestan, Ostrzeżenia i środki ostrożności)

  • EstradiolestrogenPoważna

    CARDIOVASCULAR AND OTHER RISKS Estrogens and progestins should not be used for the prevention of cardiovascular disease [see WARNINGS , Cardiovascular disorders ]. (etykieta leku Estradiol, Ostrzeżenie w ramce)

  • Estradiol + noretysteronestrogenPoważna

    Therefore, the relevance of the WHI findings regarding adverse cardiovascular events, dementia and breast cancer to lower CE plus other MPA doses, other routes of administration, or other estrogen plus progestogen products is not known. (etykieta leku Estradiol + noretysteron, Ostrzeżenie w ramce)

  • (See WARNINGS, Malignant Neoplasms, Endometrial Cancer. ) CARDIOVASCULAR AND OTHER RISKS Estrogens with or without progestins should not be used for the prevention of cardiovascular disease. (etykieta leku Estrogeny estryfikowane + metylotestosteron, Ostrzeżenie w ramce)

  • Estrogeny skoniugowaneestrogenPoważna

    Adding a progestin to estrogen therapy has been shown to reduce the risk of endometrial hyperplasia, which may be a precursor to endometrial cancer. (etykieta leku Estrogeny skoniugowane, Ostrzeżenie w ramce)

  • WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, AND PROBABLE DEMENTIA • Women taking DUAVEE should not take additional estrogens [see Warnings and Precautions (5.1) ] • There is an increased risk of endometrial cancer in a woman with a uterus who uses unopposed estrogens. (etykieta leku Estrogeny skoniugowane + bazedoksyfen, Ostrzeżenie w ramce)

  • WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS Cigarette smoking increases the risk of serious cardiovascular events from combination hormonal contraceptive (CHC) use. (etykieta leku Etonogestrel + etynyloestradiol, Ostrzeżenie w ramce)

  • Gryzeofulwinalek przeciwgrzybiczyPoważna

    Women taking estrogen-containing oral contraceptives may be at increased risk of becoming pregnant while on griseofulvin (see also PRECAUTIONS, Drug Interactions ) . (etykieta leku Gryzeofulwina, Przeciwwskazania)

  • Kwas traneksamowylek przeciwfibrynolitycznyPoważna

    Concomitant use of combined hormonal contraceptives ( 4.1 ) (etykieta leku Kwas traneksamowy, Przeciwwskazania)

  • LewonorgestrelprogestagenPoważna

    …Precautions ( 5.4 )] • Postpartum endometritis or infected abortion in the past 3 months • Known or suspected uterine or cervical malignancy • Known or suspected breast cancer or other progestin-sensitive cancer, now or in the past • Uterine bleeding of unknown etiology • Untreated acute cervicitis or vaginitis, including bacterial vaginosis or other lower genital… (etykieta leku Lewonorgestrel, Przeciwwskazania)

  • Lewonorgestrel + etynyloestradioldoustny środek antykoncepcyjnyPoważna

    …symptoms, migraine headaches with aura, or over age 35 with any migraine headaches [see Warnings and Precautions (5.7) ] Current or history of breast cancer or other estrogen- or progestin-sensitive cancer Liver tumors, acute viral hepatitis, or severe (decompensated) cirrhosis [see Warnings and Precautions (5.2) ] Undiagnosed abnormal uterine bleeding [see… (etykieta leku Lewonorgestrel + etynyloestradiol, Przeciwwskazania)

  • Lopinawir + rytonawirlek przeciwretrowirusowyPoważna

    …jaundice with prior oral contraceptive use Past or present, benign or malignant liver tumors Known or suspected pregnancy Are receiving Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, due to the potential for ALT elevations (see WARNINGS, Risk of Liver Enzyme Elevations with Concomitant Hepatitis C Treatment ). (etykieta leku Dioctan etynodiolu + etynyloestradiol, Przeciwwskazania)

  • MedroksyprogesteronprogestagenPoważna

    • MPA Injectable Suspension, USP is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see Indications and Usage (1) and Warnings and Precautions (5.1) ] . (etykieta leku Medroksyprogesteron, Ostrzeżenie w ramce)

  • Mifeprystoninhibitor CYP3A4Poważna

    Hormonal contraceptives: Do not use with mifepristone ( 7.6 ). (etykieta leku Mifepryston, Interakcje z innymi lekami)

  • Mitapiwatinduktor CYP3A4Poważna

    Sensitive CYP3A substrates including hormonal contraceptives: Avoid concomitant use with substrates that have narrow therapeutic index. (etykieta leku Mitapiwat, Interakcje z innymi lekami)

  • Mitotaninduktor CYP3A4Poważna

    Hormonal contraceptives: Avoid concomitant use with LYSODREN. (etykieta leku Mitotan, Interakcje z innymi lekami)

  • Mizoprostolanalog prostaglandynyPoważna

    • is capable of complying with effective contraceptive measures. (etykieta leku Mizoprostol, Ostrzeżenie w ramce)

  • Nirmatrelwir + rytonawirlek przeciwwirusowyPoważna

    …jaundice with prior oral contraceptive use Past or present, benign or malignant liver tumors Known or suspected pregnancy Are receiving Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, due to the potential for ALT elevations (see WARNINGS, Risk of Liver Enzyme Elevations with Concomitant Hepatitis C Treatment ). (etykieta leku Dioctan etynodiolu + etynyloestradiol, Przeciwwskazania)

  • WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS and CONTRAINDICATED IN WOMEN WITH A BMI |GTE 30 kg/m2 • Cigarette Smoking and Serious Cardiovascular Events Cigarette smoking increases the risk of serious cardiovascular events from hormonal contraceptive use. (etykieta leku Norelgestromin + etynyloestradiol, Ostrzeżenie w ramce)

  • NoretysteronprogestagenPoważna

    CONTRAINDICATIONS Progestin-only oral contraceptives (POPs) should not be used by women who currently have the following conditions: • Known or suspected pregnancy • Known or suspected carcinoma of the breast. (etykieta leku Noretysteron, Przeciwwskazania)

  • ProgesteronprogestagenPoważna

    Coronary Heart Disease In women 50 to 59 years of age, the WHI estrogen plus progestin trial reported a relative risk for coronary heart disease (CHD) events (defined as nonfatal MI, silent MI, or CHD death) of 1.34 (95% CI, 0.82, 2.19) for CE/MPA compared placebo, with a risk difference of 5 per 10,000 WYs (23 versus 17). (etykieta leku Progesteron, Ostrzeżenia)

  • Raloksyfenselektywny modulator receptora estrogenowegoPoważna

    Concomitant Use with Systemic Estrogens : Not recommended. (etykieta leku Raloksyfen, Ostrzeżenia i środki ostrożności)

  • Rytonawirlek przeciwretrowirusowyPoważna

    …jaundice with prior oral contraceptive use Past or present, benign or malignant liver tumors Known or suspected pregnancy Are receiving Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, due to the potential for ALT elevations (see WARNINGS, Risk of Liver Enzyme Elevations with Concomitant Hepatitis C Treatment ). (etykieta leku Dioctan etynodiolu + etynyloestradiol, Przeciwwskazania)

  • Tytoń i palenieTytoń i konopiePoważna

    Cigarette smoking increases the risk of serious adverse effects on the heart and blood vessels from oral contraceptive use. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenie w ramce)

  • Tyzanidynalek zwiotczający mięśniePoważna

    Moderate or Weak CYP1A2 Inhibitors Concomitant use of Zanaflex with moderate or weak CYP1A2 inhibitors (e.g., zileuton, antiarrhythmics [amiodarone, mexiletine, propafenone, and verapamil], cimetidine, famotidine, oral contraceptives, acyclovir, and ticlopidine) should be avoided. (etykieta leku Tyzanidyna, Interakcje z innymi lekami)

  • Worykonazolazolowy lek przeciwgrzybiczyPoważna

    John's Wort (CYP450 inducer; P-gp inducer) Significantly Reduced Contraindicated Oral Contraceptives containing ethinyl estradiol and norethindrone (CYP2C19 Inhibition) Increased Monitoring for adverse reactions and toxicity related to voriconazole is recommended for concomitant administration with oral contraceptives. (etykieta leku Worykonazol, Interakcje z innymi lekami)

Umiarkowane interakcje (122)

  • Alogliptyna + metforminainhibitor DPP-4Umiarkowana

    Examples: Thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs and isoniazid Alogliptin Cytochrome (CYP) P450, CYP-Substrates or Inhibitors Clinical Impact: Insulin Secretagogues and Insulin Insulin and insulin secretagogues… (etykieta leku Alogliptyna + metformina, Interakcje z innymi lekami)

  • AminofilinametyloksantynaUmiarkowana

    Estrogen Estrogen containing oral contraceptives decrease theophylline clearance in a dose-dependent fashion. (etykieta leku Aminofilina, Interakcje z innymi lekami)

  • Amlodypina + atorwastatynadihydropirydynowy bloker kanału wapniowegoUmiarkowana

    • Oral Contraceptives: May increase plasma levels of norethindrone and ethinyl estradiol; consider this effect when selecting an oral contraceptive ( 7.5 ). (etykieta leku Amlodypina + atorwastatyna, Interakcje z innymi lekami)

  • Amoksycylinaantybiotyk penicylinowyUmiarkowana

    Amoxicillin may reduce the efficacy of oral contraceptives. (etykieta leku Amoksycylina, Interakcje z innymi lekami)

  • Amoksycylina + kwas klawulanowyantybiotyk penicylinowyUmiarkowana

    Amoxicillin and Clavulanate Potassium Extended Release Tablets may reduce efficacy of oral contraceptives. (etykieta leku Amoksycylina + kwas klawulanowy, Interakcje z innymi lekami)

  • Ampicylinaantybiotyk penicylinowyUmiarkowana

    Oral Contraceptives : May be less effective and increased breakthrough bleeding may occur. (etykieta leku Ampicylina, Interakcje z innymi lekami)

  • Aprepitantinhibitor CYP3A4Umiarkowana

    Hormonal Contraceptives : Efficacy of contraceptives may be reduced during and for 28 days following administration of aprepitant. (etykieta leku Aprepitant, Ostrzeżenia i środki ostrożności)

  • Armodafinillek pobudzający OUNUmiarkowana

    Effects of NUVIGIL on CYP3A4/5 Substrates The clearance of drugs that are substrates for CYP3A4/5 (e.g., steroidal contraceptives, cyclosporine, midazolam, and triazolam) may be increased by NUVIGIL via induction of metabolic enzymes, which results in lower systemic exposure. (etykieta leku Armodafinil, Interakcje z innymi lekami)

  • Atazanawirlek przeciwretrowirusowyUmiarkowana

    Hormonal contraceptives: ethinyl estradiol and norgestimate or norethindrone ↓ ethinyl estradiol ↑ norgestimate c ↑ ethinyl estradiol ↑ norethindrone d Use caution if considering coadministration of oral contraceptives with REYATAZ or REYATAZ with ritonavir. (etykieta leku Atazanawir, Interakcje z innymi lekami)

  • AtorwastatynastatynaUmiarkowana

    • Oral Contraceptives: May increase plasma levels of norethindrone and ethinyl estradiol; consider this effect when selecting an oral contraceptive ( 7.3 ). (etykieta leku Atorwastatyna, Interakcje z innymi lekami)

  • Azelastyna + flutykazonlek przeciwhistaminowyUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • BeklometazonkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • BetametazonkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Bosentaninduktor CYP3A4Umiarkowana

    Hormonal contraceptives: TRACLEER use decreases contraceptive exposure and reduces effectiveness ( 7.2 ). (etykieta leku Bosentan, Interakcje z innymi lekami)

  • BudezonidkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Budezonid + formoterolkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Cenobamatlek przeciwdrgawkowyUmiarkowana

    Oral Contraceptives: Effectiveness of hormonal oral contraceptives may be reduced when administered concomitantly with XCOPRI. (etykieta leku Cenobamat, Interakcje z innymi lekami)

  • Chininalek przeciwmalarycznyUmiarkowana

    Oral Contraceptives (Estrogen, Progestin) In 7 healthy females who were using single-ingredient progestin or combination estrogen-containing oral contraceptives, the pharmacokinetic parameters of a single 600 mg dose of quinine sulfate were not altered in comparison to those observed in 7 age-matched female control subjects not using oral contraceptives. (etykieta leku Chinina, Interakcje z innymi lekami)

  • Chlorek wapniaUmiarkowana

    Drugs That Increase the Risk of Hypercalcemia Increase frequency of monitoring of calcium concentrations in patients taking concomitant Calcium Chloride Injection and other drugs that increase the risk of hypercalcemia (e.g., calcipotriene, estrogen, lithium, parathyroid hormone, teriparatide, thiazide diuretics, Vitamin A, and Vitamin D). (etykieta leku Chlorek wapnia, Interakcje z innymi lekami)

  • Safe and effective induction of ovulation with use of PREGNYL requires monitoring of ovarian response with serum estradiol and transvaginal ultrasound on a regular basis. (etykieta leku Choriogonadotropina alfa, Ostrzeżenia)

  • CyklezonidkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Cyklosporynalek immunosupresyjnyUmiarkowana

    …itraconazole clarithromycin Amiodarone verapamil ketoconazole erythromycin Bromocriptine voriconazole quinupristin/ dalfopristin colchicine danazol imatinib metoclopramide nefazodone oral contraceptives HIV Protease Inhibitors The HIV protease inhibitors (e.g., indinavir, nelfinavir, ritonavir, and saquinavir) are known to inhibit cytochrome P-450 3A and thus could… (etykieta leku Cyklosporyna, Interakcje z innymi lekami)

  • Darunawirlek przeciwretrowirusowyUmiarkowana

    Hormonal contraceptives : Effective alternative (non-hormonal) contraceptive method or a barrier method of contraception is recommended [see Use in Specific Populations (8.3) ] . ethinyl estradiol, norethindrone, drospirenone ↓ ethinyl estradiol ↓ norethindrone drospirenone: effects unknown For co-administration with drospirenone, clinical monitoring is recommended… (etykieta leku Darunawir, Interakcje z innymi lekami)

  • Darunawir + kobicystatlek przeciwretrowirusowyUmiarkowana

    Hormonal contraceptives: Additional or alternative (non-hormonal) forms of contraception should be considered when estrogen-containing contraceptives are co-administered with PREZCOBIX or PREZCOBIX PED [see Use in Specific Populations (8.3) ] . drospirenone/ethinylestradiol ↑ drospirenone ↓ ethinylestradiol For co-administration with drospirenone, clinical monitoring… (etykieta leku Darunawir + kobicystat, Interakcje z innymi lekami)

  • Deferazyrokssuplement żelazaUmiarkowana

    …budesonide, buspirone, conivaptan, cyclosporine, darifenacin, darunavir, dasatinib, dihydroergotamine, dronedarone, eletriptan, eplerenone, ergotamine, everolimus, felodipine, fentanyl, hormonal contraceptive agents, indinavir, fluticasone, lopinavir, lovastatin, lurasidone, maraviroc, midazolam, nisoldipine, pimozide, quetiapine, quinidine, saquinavir, sildenafil,… (etykieta leku Deferazyroks, Interakcje z innymi lekami)

  • DeflazakortkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • DeksametazonkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Deutetrabenazynainhibitor VMAT2Umiarkowana

    Chronic increase in serum prolactin levels (although not evaluated in the AUSTEDO XR, AUSTEDO, or tetrabenazine development programs) has been associated with low levels of estrogen and increased risk of osteoporosis. (etykieta leku Deutetrabenazyna, Ostrzeżenia i środki ostrożności)

  • DezonidkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Diwalproeks (walproinian)lek przeciwdrgawkowyUmiarkowana

    Aspirin, carbapenem antibiotics, estrogen-containing hormonal contraceptives, methotrexate: Monitoring of valproate concentrations is recommended ( 7.1 ) (etykieta leku Diwalproeks (walproinian), Interakcje z innymi lekami)

  • Dolutegrawirlek przeciwretrowirusowyUmiarkowana

    …following drugs can be coadministered with dolutegravir without a dose adjustment: atazanavir/ritonavir, darunavir/ritonavir, elbasvir/grazoprevir, methadone, midazolam, omeprazole, oral contraceptives containing norgestimate and ethinyl estradiol, prednisone, rifabutin, rilpivirine, sofosbuvir/velpatasvir, and tenofovir [see Clinical Pharmacology ( 12.3 )] . (etykieta leku Dolutegrawir, Interakcje z innymi lekami)

  • Drospirenon + etynyloestradioldoustny środek antykoncepcyjnyUmiarkowana

    COCs containing DRSP may be associated with a higher risk of venous thromboembolism (VTE) than COCs containing levonorgestrel or some other progestins. (etykieta leku Drospirenon + etynyloestradiol, Ostrzeżenia i środki ostrożności)

  • For patients with CF taking hormonal contraceptives who develop rash, consider interrupting TRIKAFTA and hormonal contraceptives. (etykieta leku Eleksakaftor + tezakaftor + iwakaftor, Interakcje z innymi lekami)

  • The potential risks and benefits associated with coadministration of norgestimate/ethinyl estradiol with GENVOYA should be considered, particularly in patients who have risk factors for these events. (etykieta leku Elwitegrawir + kobicystat + emtrycytabina + tenofowir, Interakcje z innymi lekami)

  • Eslikarbazepinalek przeciwdrgawkowyUmiarkowana

    Hormonal Contraceptives: APTIOM may decrease the effectiveness of hormonal contraceptives. (etykieta leku Eslikarbazepina, Interakcje z innymi lekami)

  • Felbamatlek przeciwdrgawkowyUmiarkowana

    Effects of Felbatol ® on Low-Dose Combination Oral Contraceptives A group of 24 nonsmoking, healthy white female volunteers established on an oral contraceptive regimen containing 30 µg ethinyl estradiol and 75 µg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle (day 15) to midcycle (day 14) of two consecutive oral contraceptive… (etykieta leku Felbamat, Interakcje z innymi lekami)

  • Fentermina + topiramatlek pobudzający OUNUmiarkowana

    Oral Contraceptives Clinical Impact Co-administration of multiple-dose phentermine and topiramate extended-release capsules 15 mg/92 mg once daily with a single dose of oral contraceptive containing 35 µg ethinyl estradiol (estrogen component) and 1 mg norethindrone (progestin component), in obese otherwise healthy volunteers, decreased the exposure of ethinyl… (etykieta leku Fentermina + topiramat, Interakcje z innymi lekami)

  • Fenytoinalek przeciwdrgawkowyUmiarkowana

    …omeprazole Sulfonamides Sulfamethizole, sulfaphenazole, sulfadiazine, sulfamethoxazole-trimethoprim Other Acute alcohol intake, amiodarone, chloramphenicol, chlordiazepoxide, disulfiram, estrogen, fluvastatin, isoniazid, methylphenidate, phenothiazines, salicylates, ticlopidine, tolbutamide, trazodone, warfarin Drugs that may decrease phenytoin serum levels Antacids… (etykieta leku Fenytoina, Interakcje z innymi lekami)

  • Flibanserynalek działający depresyjnie na OUNUmiarkowana

    Weak CYP3A4 Inhibitors Examples Oral contraceptives, cimetidine, fluoxetine, ginkgo, ranitidine Clinical Implications The concomitant use of ADDYI with multiple weak CYP3A4 inhibitors may increase the risk of adverse reactions. (etykieta leku Flibanseryna, Interakcje z innymi lekami)

  • FludrokortyzonkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Flukonazolazolowy lek przeciwgrzybiczyUmiarkowana

    There were no relevant effects on hormone level in the 50 mg fluconazole study, while at 200 mg daily, the AUCs of ethinyl estradiol and levonorgestrel were increased 40% and 24%, respectively. (etykieta leku Flukonazol, Interakcje z innymi lekami)

  • FlunizolidkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • FluocynonidkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • FlutykazonkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Flutykazon + salmeterolkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • FolitropinaUmiarkowana

    Use of ultrasound monitoring of ovarian response and/or measurement of serum estradiol levels is important to minimize the risk of overstimulation [see Warnings and Precautions (5.8) ] . (etykieta leku Folitropina, Ostrzeżenia i środki ostrożności)

  • Fosamprenawirlek przeciwretrowirusowyUmiarkowana

    Fosamprenavir calcium: ↓ Amprenavir ↓ Ethinyl estradiol May lead to loss of virologic response. a Fosamprenavir calcium/ritonavir: ↓ Ethinyl estradiol Increased risk of transaminase elevations. (etykieta leku Fosamprenawir, Interakcje z innymi lekami)

  • Fosaprepitantinhibitor CYP3A4Umiarkowana

    Hormonal Contraceptives: Efficacy of contraceptives may be reduced during treatment and for 1 month following administration of the last dose of either fosaprepitant or oral aprepitant. (etykieta leku Fosaprepitant, Ostrzeżenia i środki ostrożności)

  • Fosfenytoinalek przeciwdrgawkowyUmiarkowana

    …omeprazole Sulfonamides Sulfamethizole, sulfaphenazole, sulfadiazine, sulfamethoxazole-trimethoprim Other Acute alcohol intake, amiodarone, chloramphenicol, chlordiazepoxide, disulfiram, estrogen, fluvastatin, isoniazid, methylphenidate, phenothiazines, salicylates, ticlopidine, tolbutamide, trazodone, warfarin Drugs that may decrease phenytoin serum levels Antineoplastic… (etykieta leku Fosfenytoina, Interakcje z innymi lekami)

  • Gabapentynalek przeciwdrgawkowyUmiarkowana

    Oral Contraceptive Based on AUC and half-life, multiple-dose pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl estradiol were similar with and without coadministration of gabapentin (400 mg three times a day; N=13). (etykieta leku Gabapentyna, Interakcje z innymi lekami)

  • Glimepirydpochodna sulfonylomocznikaUmiarkowana

    …somatropin, protease inhibitors, atypical antipsychotic medications (e.g., olanzapine and clozapine), barbiturates, diazoxide, laxatives, rifampin, thiazides and other diuretics, corticosteroids, phenothiazines, thyroid hormones, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics (e.g., epinephrine, albuterol, terbutaline), and isoniazid. (etykieta leku Glimepiryd, Interakcje z innymi lekami)

  • Glipizydpochodna sulfonylomocznikaUmiarkowana

    …GLUCOTROL XL, leading to worsening glycemic control: atypical antipsychotics (e.g., olanzapine and clozapine), corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline),… (etykieta leku Glipizyd, Interakcje z innymi lekami)

  • GoserelinaUmiarkowana

    Tumor Flare Phenomenon Initially, ZOLADEX, like other GnRH agonists, causes transient increases in serum levels of testosterone in men with prostate cancer, and estrogen in women with breast cancer. (etykieta leku Goserelina, Ostrzeżenia i środki ostrożności)

  • HalobetazolkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • HialuronidazaUmiarkowana

    • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (etykieta leku Hialuronidaza, Interakcje z innymi lekami)

  • HydrokortyzonkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Insulina aspartinsulinaUmiarkowana

    Progestogens increase insulin secretion and create insulin resistance, the effect varying with different progestational agents. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Insulina degludecinsulinaUmiarkowana

    Progestogens increase insulin secretion and create insulin resistance, the effect varying with different progestational agents. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Insulina detemirinsulinaUmiarkowana

    Progestogens increase insulin secretion and create insulin resistance, the effect varying with different progestational agents. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Insulina glargineinsulinaUmiarkowana

    Progestogens increase insulin secretion and create insulin resistance, the effect varying with different progestational agents. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Insulina lisproinsulinaUmiarkowana

    Progestogens increase insulin secretion and create insulin resistance, the effect varying with different progestational agents. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Progestogens increase insulin secretion and create insulin resistance, the effect varying with different progestational agents. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Itrakonazolazolowy lek przeciwgrzybiczyUmiarkowana

    Contraceptives Dienogest Ulipristal Monitor for adverse reactions. (etykieta leku Itrakonazol, Interakcje z innymi lekami)

  • Kabotegrawirlek przeciwretrowirusowyUmiarkowana

    Drugs without Clinically Significant Interactions with Cabotegravir Based on drug interaction study results, the following drugs can be coadministered with cabotegravir without a dose adjustment: etravirine, midazolam, oral contraceptives containing levonorgestrel and ethinyl estradiol, rifabutin, and rilpivirine [see Clinical Pharmacology ( 12.3 )] . (etykieta leku Kabotegrawir, Interakcje z innymi lekami)

  • Karbamazepinalek przeciwdrgawkowyUmiarkowana

    EQUETRO can reduce the effectiveness of hormonal contraceptives. (etykieta leku Karbamazepina, Ostrzeżenia i środki ostrożności)

  • KlobetazolkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Kokainaśrodek znieczulający miejscowoUmiarkowana

    Plasma cholinesterase activity may be decreased by chronic administration of certain monoamine oxidase inhibitors, oral contraceptives, glucocorticoids, antimyasthenics (neostigmine), cyclophosphamide, and possibly thiotepa. (etykieta leku Kokaina, Interakcje z innymi lekami)

  • Kolesewelamsekwestrant kwasów żółciowychUmiarkowana

    Concomitant use with colesevelam hydrochloride may decrease the exposure of the following drugs: Drugs with a narrow therapeutic index (e.g., cyclosporine), phenytoin, thyroid hormone replacement therapy, warfarin, oral contraceptives containing ethinyl estradiol and norethindrone, olmesartan medoxomil, and sulfonylureas (glimepiride, glipizide, glyburide). (etykieta leku Kolesewelam, Interakcje z innymi lekami)

  • Kolestyraminasekwestrant kwasów żółciowychUmiarkowana

    Drug Interactions Cholestyramine for Oral Suspension USP may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic), or propranolol (basic), as well as tetracycline, penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis. (etykieta leku Kolestyramina, Interakcje z innymi lekami)

  • Kwas foliowy (foliany)Witaminy i minerałyUmiarkowana

    …proteins may be elevated in the serum. d) Sex-steroid binding globulins are increased and result in elevated levels of total circulating sex steroids and corticoids; however, free or biologically active levels remain unchanged. e) Triglycerides and phospholipids may be increased. f) Glucose tolerance may be decreased. g) Serum folate levels may be depressed. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Środki ostrożności)

  • Drugs Affecting Lipid Metabolism Estrogens, oral contraceptives, and clofibrate (and perhaps other lipid-lowering drugs) increase hepatic cholesterol secretion and encourage cholesterol gallstone formation and hence may counteract the effectiveness of URSO 250 and URSO Forte. (etykieta leku Kwas ursodeoksycholowy, Interakcje z innymi lekami)

  • Kwas walproinowylek przeciwdrgawkowyUmiarkowana

    Aspirin, carbapenem antibiotics, estrogen-containing hormonal contraceptives: Monitoring of valproate concentrations is recommended (7.1) (etykieta leku Kwas walproinowy, Interakcje z innymi lekami)

  • Lamotryginalek przeciwdrgawkowyUmiarkowana

    Concomitant Use with Estrogen-Containing Products, Including Oral Contraceptives Some estrogen-containing oral contraceptives have been shown to decrease serum concentrations of lamotrigine [see Clinical Pharmacology ( 12.3 )] . (etykieta leku Lamotrygina, Ostrzeżenia i środki ostrożności)

  • Leflunomidlek immunosupresyjnyUmiarkowana

    Effect on Oral Contraceptives Teriflunomide may increase the systemic exposures of ethinylestradiol and levonorgestrel. (etykieta leku Leflunomid, Interakcje z innymi lekami)

  • LenalidomidUmiarkowana

    Females must commit either to abstain continuously from heterosexual sexual intercourse or to use two methods of reliable birth control, beginning 4 weeks prior to initiating treatment with REVLIMID, during therapy, during dose interruptions and continuing for 4 weeks following discontinuation of REVLIMID therapy. (etykieta leku Lenalidomid, Ostrzeżenia i środki ostrożności)

  • Lewotyroksynahormon tarczycyUmiarkowana

    …and blood components may be affected by oral contraceptives: a) Increased prothrombin and factors VII, VIII, IX and X; decreased antithrombin III; increased platelet aggregability. b) Increased thyroid binding globulin (TBG), leading to increased circulating total thyroid hormone as measured by protein-bound iodine (PBI), T 4 by column or by radioimmunoassay. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Środki ostrożności)

  • Lewotyroksyna + liotyroninahormon tarczycyUmiarkowana

    …and blood components may be affected by oral contraceptives: a) Increased prothrombin and factors VII, VIII, IX and X; decreased antithrombin III; increased platelet aggregability. b) Increased thyroid binding globulin (TBG), leading to increased circulating total thyroid hormone as measured by protein-bound iodine (PBI), T 4 by column or by radioimmunoassay. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Środki ostrożności)

  • Liotyroninahormon tarczycyUmiarkowana

    …and blood components may be affected by oral contraceptives: a) Increased prothrombin and factors VII, VIII, IX and X; decreased antithrombin III; increased platelet aggregability. b) Increased thyroid binding globulin (TBG), leading to increased circulating total thyroid hormone as measured by protein-bound iodine (PBI), T 4 by column or by radioimmunoassay. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Środki ostrożności)

  • LomitapidUmiarkowana

    Careful titration may then be considered based on LDL-C response and safety/tolerability to a maximum recommended dosage of 30 mg daily except when coadministered with oral contraceptives, in which case the maximum recommended lomitapide dosage is 40 mg daily [see Dosage and Administration (2.3) and Drug Interactions (7.2) ]. (etykieta leku Lomitapid, Ostrzeżenia i środki ostrożności)

  • Lorlatynibinduktor CYP3A4Umiarkowana

    Advise females of reproductive potential to use an effective non-hormonal method of contraception, since LORBRENA can render hormonal contraceptives ineffective, during treatment with LORBRENA and for at least 6 months after the final dose. (etykieta leku Lorlatynib, Ostrzeżenia i środki ostrożności)

  • MetyloprednizolonkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • MetyraponUmiarkowana

    This may be of clinical significance if a woman becomes pregnant shortly after discontinuing oral contraceptives. h) Increased sulfobromophthalein and other abnormalities in liver function tests may occur. i) Plasma levels of trace minerals may be altered. j) Response to the metyrapone test may be reduced. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Środki ostrożności)

  • Modafinillek pobudzający OUNUmiarkowana

    Effects of PROVIGIL on CYP3A4/5 Substrates The clearance of drugs that are substrates for CYP3A4/5 (e.g., steroidal contraceptives, cyclosporine, midazolam, and triazolam) may be increased by PROVIGIL via induction of metabolic enzymes, which results in lower systemic exposure. (etykieta leku Modafinil, Interakcje z innymi lekami)

  • MometazonkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Mykofenolanlek immunosupresyjnyUmiarkowana

    Mycophenolate mofetil may reduce effectiveness of oral contraceptives. (etykieta leku Mykofenolan, Interakcje z innymi lekami)

  • Newirapinalek przeciwretrowirusowyUmiarkowana

    When these oral contraceptives are used for hormonal regulation during nevirapine therapy, the therapeutic effect of the hormonal therapy should be monitored. (etykieta leku Newirapina, Interakcje z innymi lekami)

  • NintedanibUmiarkowana

    Advise women taking oral hormonal contraceptives experiencing vomiting, diarrhea, or other conditions where the drug absorption may be reduced to use alternative highly effective contraception. (etykieta leku Nintedanib, Ostrzeżenia i środki ostrożności)

  • Norgestrel + etynyloestradioldoustny środek antykoncepcyjnyUmiarkowana

    Effects of Other Drugs on Combined Oral Contraceptives Substances decreasing the plasma concentrations of COCs and potentially diminishing the efficacy of COCs Drugs or herbal products that induce certain enzymes, including cytochrome P450 3A4 (CYP3A4), may decrease the plasma concentrations of COCs and potentially diminish the effectiveness of COCs or increase… (etykieta leku Norgestrel + etynyloestradiol, Interakcje z innymi lekami)

  • Norgestymat + etynyloestradioldoustny środek antykoncepcyjnyUmiarkowana

    Effects of Other Drugs on Combined Oral Contraceptives Substances decreasing the plasma concentrations of COCs Drugs or herbal products that induce certain enzymes, including cytochrome P450 3A4 (CYP3A4), may decrease the plasma concentrations of COCs and potentially diminish the effectiveness of COCs or increase breakthrough bleeding. (etykieta leku Norgestymat + etynyloestradiol, Interakcje z innymi lekami)

  • Okskarbazepinalek przeciwdrgawkowyUmiarkowana

    Oral Contraceptive: TRILEPTAL may decrease the effectiveness of hormonal contraceptives ( 7.3 ) (etykieta leku Okskarbazepina, Interakcje z innymi lekami)

  • OktreotydUmiarkowana

    Intervention: Decreased bioavailability may potentially diminish the effectiveness of combined oral contraceptives (COCs) or increase breakthrough bleeding. (etykieta leku Oktreotyd, Interakcje z innymi lekami)

  • Olopatadyna + mometazonlek przeciwhistaminowyUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Perampanellek przeciwdrgawkowyUmiarkowana

    Contraceptives: 12 mg once daily may decrease the effectiveness of hormonal contraceptives containing levonorgestrel ( 7.1 ) (etykieta leku Perampanel, Interakcje z innymi lekami)

  • Pioglitazon + glimepirydtiazolidynodionUmiarkowana

    …somatropin, protease inhibitors, atypical antipsychotic medications (e.g., olanzapine and clozapine), barbiturates, diazoxide, laxatives, rifampin, thiazides and other diuretics, corticosteroids, phenothiazines, thyroid hormones, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics (e.g., epinephrine, albuterol, terbutaline), and isoniazid. (etykieta leku Pioglitazon + glimepiryd, Interakcje z innymi lekami)

  • Pitolisantlek wydłużający odstęp QTUmiarkowana

    Sensitive CYP3A4 Substrates (including hormonal contraceptives): WAKIX may reduce effectiveness of sensitive CYP3A4 substrates. (etykieta leku Pitolisant, Interakcje z innymi lekami)

  • PomalidomidUmiarkowana

    Females must commit either to abstain continuously from heterosexual sexual intercourse or to use 2 methods of reliable birth control, beginning 4 weeks prior to initiating treatment with POMALYST, during therapy, during dose interruptions, and continuing for 4 weeks following discontinuation of POMALYST therapy. (etykieta leku Pomalidomid, Ostrzeżenia i środki ostrożności)

  • PrednizolonkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • PrednizonkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Propylotiouracyllek przeciwtarczycowyUmiarkowana

    …and blood components may be affected by oral contraceptives: a) Increased prothrombin and factors VII, VIII, IX and X; decreased antithrombin III; increased platelet aggregability. b) Increased thyroid binding globulin (TBG), leading to increased circulating total thyroid hormone as measured by protein-bound iodine (PBI), T 4 by column or by radioimmunoassay. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Środki ostrożności)

  • Roflumilastinhibitor PDE4Umiarkowana

    Oral Contraceptives Containing Gestodene and Ethinyl Estradiol The co-administration of DALIRESP (500 mcg) with oral contraceptives containing gestodene and ethinyl estradiol may increase roflumilast systemic exposure and may result in increased side effects. (etykieta leku Roflumilast, Interakcje z innymi lekami)

  • Ropinirolagonista dopaminyUmiarkowana

    Estrogens Population pharmacokinetic analysis revealed that higher doses of estrogens (usually associated with hormone replacement therapy) reduced the clearance of ropinirole. (etykieta leku Ropinirol, Interakcje z innymi lekami)

  • RyfampicynaantybiotykUmiarkowana

    Drug Interactions Reduced efficacy and increased incidence of breakthrough bleeding and menstrual irregularities have been associated with concomitant use of rifampin. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • RyfapentynaantybiotykUmiarkowana

    Hormonal Contraceptives PRIFTIN may reduce the effectiveness of hormonal contraceptives. (etykieta leku Ryfapentyna, Interakcje z innymi lekami)

  • RyluzolUmiarkowana

    The concomitant use of strong or moderate CYP1A2 inhibitors (e.g., ciprofloxacin, enoxacin, fluvoxamine, methoxsalen, mexiletine, oral contraceptives, thiabendazole, vemurafenib, zileuton) with TIGLUTIK may increase the risk of TIGLUTIK - associated adverse reactions [see Clinical Pharmacology (12.3) ]. (etykieta leku Ryluzol, Interakcje z innymi lekami)

  • SomatropinaUmiarkowana

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etykieta leku Somatropina, Interakcje z innymi lekami)

  • SugammadeksUmiarkowana

    Therefore, the administration of a bolus dose of BRIDION is considered to be equivalent to missing dose(s) of oral contraceptives containing an estrogen or progestogen. (etykieta leku Sugammadeks, Interakcje z innymi lekami)

  • Suksametoniumlek blokujący przewodnictwo nerwowo-mięśnioweUmiarkowana

    The neuromuscular blocking effect of succinylcholine may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase [see Warnings and Precautions (5.9) ]. (etykieta leku Suksametonium, Interakcje z innymi lekami)

  • Suzetryginainduktor CYP3A4Umiarkowana

    …contraceptives containing progestins other than levonorgestrel and norethindrone should use additional nonhormonal contraceptives (such as condoms) or use alternative contraceptives (e.g., a combined oral contraceptive containing ethinyl estradiol as the estrogen and levonorgestrel or norethindrone as the progestin, an intrauterine system) during JOURNAVX treatment and… (etykieta leku Suzetrygina, Ostrzeżenia i środki ostrożności)

  • Takrolimuslek immunosupresyjnyUmiarkowana

    Mild or Moderate CYP3A Inhibitors: Clotrimazole, antibiotics (e.g., verapamil, diltiazem, nifedipine, nicardipine), amiodarone, danazol, ethinyl estradiol, cimetidine, lansoprazole and omeprazole May increase tacrolimus whole blood trough concentrations and increase the risk of serious adverse reactions (e.g., neurotoxicity, QT prolongation) [see Warnings and… (etykieta leku Takrolimus, Interakcje z innymi lekami)

  • Tamoksyfenselektywny modulator receptora estrogenowegoUmiarkowana

    Hypercalcemia in Patients with Metastatic Breast Cancer As with other additive hormonal therapy (estrogens and androgens), hypercalcemia has been reported in some breast cancer patients with bone metastases within a few weeks of starting treatment with tamoxifen. (etykieta leku Tamoksyfen, Ostrzeżenia i środki ostrożności)

  • TeofilinametyloksantynaUmiarkowana

    Estrogen Estrogen containing oral contraceptives decrease theophylline clearance in a dose-dependent fashion. (etykieta leku Teofilina, Interakcje z innymi lekami)

  • Teryflunomidlek immunosupresyjnyUmiarkowana

    Effect of AUBAGIO on Oral Contraceptives AUBAGIO may increase the systemic exposures of ethinylestradiol and levonorgestrel. (etykieta leku Teryflunomid, Interakcje z innymi lekami)

  • Teryparatydhormon tarczycyUmiarkowana

    …and blood components may be affected by oral contraceptives: a) Increased prothrombin and factors VII, VIII, IX and X; decreased antithrombin III; increased platelet aggregability. b) Increased thyroid binding globulin (TBG), leading to increased circulating total thyroid hormone as measured by protein-bound iodine (PBI), T 4 by column or by radioimmunoassay. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Środki ostrożności)

  • Tetrabenazynainhibitor VMAT2Umiarkowana

    Chronic increase in serum prolactin levels (although not evaluated in the tetrabenazine development program) has been associated with low levels of estrogen and increased risk of osteoporosis. (etykieta leku Tetrabenazyna, Ostrzeżenia i środki ostrożności)

  • Tiamazollek przeciwtarczycowyUmiarkowana

    …and blood components may be affected by oral contraceptives: a) Increased prothrombin and factors VII, VIII, IX and X; decreased antithrombin III; increased platelet aggregability. b) Increased thyroid binding globulin (TBG), leading to increased circulating total thyroid hormone as measured by protein-bound iodine (PBI), T 4 by column or by radioimmunoassay. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Środki ostrożności)

  • Tocilizumablek immunosupresyjnyUmiarkowana

    Exercise caution when coadministering TOFIDENCE with CYP3A4 substrate drugs where decrease in effectiveness is undesirable, e.g., oral contraceptives, lovastatin, atorvastatin, etc. (etykieta leku Tocilizumab, Interakcje z innymi lekami)

  • Topiramatlek przeciwdrgawkowyUmiarkowana

    Contraceptives: decreased contraceptive efficacy and increased breakthrough bleeding, especially at doses greater than 200 mg per day ( 7.4 ) (etykieta leku Topiramat, Interakcje z innymi lekami)

  • TriamcynolonkortykosteroidUmiarkowana

    The amount of both steroids should be considered in the choice of an oral contraceptive. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • Tyrzepatydagonista receptora GLP-1Umiarkowana

    Progestogens increase insulin secretion and create insulin resistance, the effect varying with different progestational agents. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Ostrzeżenia)

  • UliprystalUmiarkowana

    Advise women to follow the instructions on the initiation or resumption of hormonal contraceptives after ella intake [see Dosage and Administration(2.2) ]. (etykieta leku Uliprystal, Ostrzeżenia i środki ostrożności)

  • Warfarynalek przeciwzakrzepowyUmiarkowana

    …carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital,… (etykieta leku Warfaryna, Interakcje z innymi lekami)

  • Oral Contraceptives: Decreased efficacy possibly resulting in pregnancy; use a different or additional form of contraception. (etykieta leku Zasadowy cytrynian bizmutu + metronidazol + tetracyklina, Interakcje z innymi lekami)

Wzmianki o niewielkim znaczeniu (50)

  • Akarbozalek przeciwcukrzycowyNiewielka

    These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid. (etykieta leku Akarboza, Interakcje z innymi lekami)

  • AlbendazolNiewielka

    Advise women of reproductive potential to use effective birth control for the duration of ALBENZA therapy and for one month after end of therapy. (etykieta leku Albendazol, Ostrzeżenia i środki ostrożności)

  • Ampicylina + sulbaktamantybiotyk penicylinowyNiewielka

    A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • BeksarotenretinoidNiewielka

    Drug products which may be affected include oral or other systemic hormonal contraceptives. (etykieta leku Beksaroten, Interakcje z innymi lekami)

  • A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • Butalbital + paracetamolbarbituranNiewielka

    A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • Sixteen (16) drugs tested did not show an in vitro interaction with LOKELMA (allopurinol, apixaban, aspirin, captopril, cyclosporine, digoxin, ethinyl estradiol, lisinopril, magnesium, metformin, phenytoin, prednisone, propranolol, quinapril, spironolactone and ticagrelor). (etykieta leku Cyklokrzemian sodowo-cyrkonowy, Interakcje z innymi lekami)

  • Dapagliflozyna + metforminainhibitor SGLT2Niewielka

    These medications include thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid. (etykieta leku Dapagliflozyna + metformina, Interakcje z innymi lekami)

  • Demeklocyklinaantybiotyk tetracyklinowyNiewielka

    A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • Dihydroergotaminaalkaloid sporyszuNiewielka

    Oral Contraceptives The effect of oral contraceptives on the pharmacokinetics of Dihydroergotamine Mesylate Injection, USP has not been studied. (etykieta leku Dihydroergotamina, Interakcje z innymi lekami)

  • Doksycyklinaantybiotyk tetracyklinowyNiewielka

    A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • Efawirenzlek przeciwretrowirusowyNiewielka

    Hormonal contraceptives: Oral Ethinyl estradiol/ Norgsetimate Implant Etonogestrel ↑ active metabolites of norgestimate * ↓ etonogestrel A reliable method of barrier contraception should be used in addition to hormonal contraceptives. (etykieta leku Efawirenz, Interakcje z innymi lekami)

  • Efawirenz + lamiwudyna + tenofowirlek przeciwretrowirusowyNiewielka

    Hormonal contraceptives: Oral Ethinyl estradiol/ Norgestimate ↓ active metabolites of norgestimate A reliable method of barrier contraception should be used in addition to hormonal contraceptives. (etykieta leku Efawirenz + lamiwudyna + tenofowir, Interakcje z innymi lekami)

  • Eksenatydagonista receptora GLP-1Niewielka

    For oral medications that are dependent on threshold concentrations for efficacy, such as contraceptives and antibiotics, patients should be advised to take those drugs at least 1 hour before BYETTA injection. (etykieta leku Eksenatyd, Interakcje z innymi lekami)

  • Empagliflozyna + metforminainhibitor SGLT2Niewielka

    These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid. (etykieta leku Empagliflozyna + metformina, Interakcje z innymi lekami)

  • Estradiol + dienogestdoustny środek antykoncepcyjnyNiewielka

    Effects of Combined Oral Contraceptives on Other Drugs COCs containing ethinyl estradiol may inhibit the metabolism of other compounds. (etykieta leku Estradiol + dienogest, Interakcje z innymi lekami)

  • FenobarbitalbarbituranNiewielka

    A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • Glibenklamidpochodna sulfonylomocznikaNiewielka

    These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid. (etykieta leku Glibenklamid, Interakcje z innymi lekami)

  • Glibenklamid + metforminapochodna sulfonylomocznikaNiewielka

    Examples: Thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, and isoniazid. (etykieta leku Glibenklamid + metformina, Interakcje z innymi lekami)

  • Glipizyd + metforminapochodna sulfonylomocznikaNiewielka

    These drugs include thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid. (etykieta leku Glipizyd + metformina, Środki ostrożności)

  • Drugs that may cause hypercalcemia: Vitamin D, vitamin A, thiazide diuretics, estrogen, calcipotriene and teriparatide administration may cause hypercalcemia. (etykieta leku Glukonian wapnia, Interakcje z innymi lekami)

  • IzotretynoinaretinoidNiewielka

    Oral Contraceptives Isotretinoin Capsules did not result in clinically significant changes in the pharmacokinetics of norethindrone and ethinyl estradiol when used concomitantly with a norethindrone and ethinyl estradiol oral contraceptive [see Clinical Pharmacology ( 12.3 )]. (etykieta leku Izotretynoina, Interakcje z innymi lekami)

  • KlobazambenzodiazepinaNiewielka

    Effect of SYMPAZAN ® on Other Drugs Hormonal Contraceptives SYMPAZAN ® is a weak CYP3A4 inducer. (etykieta leku Klobazam, Interakcje z innymi lekami)

  • Klozapinalek przeciwpsychotycznyNiewielka

    Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine. (etykieta leku Klozapina, Interakcje z innymi lekami)

  • Kwas ryzedronowybisfosfonianNiewielka

    Hormone Therapy Concomitant use of Risedronate sodium delayed-release with estrogens and estrogen agonist/antagonists has not been studied. (etykieta leku Kwas ryzedronowy, Interakcje z innymi lekami)

  • Lewetyracetamlek przeciwdrgawkowyNiewielka

    Potential pharmacokinetic interactions of or with levetiracetam were assessed in clinical pharmacokinetic studies (phenytoin, valproate, warfarin, digoxin, oral contraceptive, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients. (etykieta leku Lewetyracetam, Interakcje z innymi lekami)

  • Linagliptyna + metforminainhibitor DPP-4Niewielka

    These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid. (etykieta leku Linagliptyna + metformina, Interakcje z innymi lekami)

  • MacytentanNiewielka

    Advise patients who can become pregnant to use effective contraceptive methods prior to initiation of treatment, during treatment, and for one month after discontinuation of treatment with OPSUMIT. (etykieta leku Macytentan, Ostrzeżenia i środki ostrożności)

  • MetforminabiguanidNiewielka

    Examples: Thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, and isoniazid. (etykieta leku Metformina, Interakcje z innymi lekami)

  • MetoheksitalbarbituranNiewielka

    A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • Minocyklinaantybiotyk tetracyklinowyNiewielka

    A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • Mirabegronagonista receptorów beta-adrenergicznychNiewielka

    Drug interaction studies were conducted in adult patients to investigate the effect of coadministered drugs on the pharmacokinetics of mirabegron and the effect of mirabegron on the pharmacokinetics of coadministered drugs (e.g., ketoconazole, rifampin, solifenacin succinate, tamsulosin, and oral contraceptives) [see Clinical Pharmacology ( 12.3 )] . (etykieta leku Mirabegron, Interakcje z innymi lekami)

  • Nimodypinadihydropirydynowy bloker kanału wapniowegoNiewielka

    Moderate and weak CYP3A4 inhibitors include alprozalam, ameprenavir, amiodarone, aprepitant, atazanavir, cimetidine, cyclosporine, diltiazem, erythromycin, fluconazole, fluoxetine, isoniazid, oral contraceptives, quinuprestin/dalfopristin, valproic acid, and verapamil. (etykieta leku Nimodypina, Interakcje z innymi lekami)

  • Noretysteron + etynyloestradioldoustny środek antykoncepcyjnyNiewielka

    Changes in Contraceptive Effectiveness Associated with Co-Administration of Other Products If a woman on hormonal contraceptives takes a drug or herbal product that induces enzymes, including CYP3A4, that metabolize contraceptive hormones, counsel her to use additional contraception or a different method of contraception. (etykieta leku Noretysteron + etynyloestradiol, Interakcje z innymi lekami)

  • Pilokarpinaagonista cholinergicznyNiewielka

    …performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren's efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone. (etykieta leku Pilokarpina, Interakcje z innymi lekami)

  • Pioglitazon + metforminatiazolidynodionNiewielka

    These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, and isoniazid. (etykieta leku Pioglitazon + metformina, Interakcje z innymi lekami)

  • Pregabalinalek przeciwdrgawkowyNiewielka

    No pharmacokinetic interactions were observed between LYRICA and carbamazepine, gabapentin, lamotrigine, oral contraceptive, phenobarbital, phenytoin, topiramate, and valproic acid. (etykieta leku Pregabalina, Interakcje z innymi lekami)

  • Prymidonlek przeciwdrgawkowyNiewielka

    A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • RepaglinidmeglitynidNiewielka

    Examples: Atypical antipsychotics (e.g., olanzapine and clozapine), calcium channel antagonists, corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), and… (etykieta leku Repaglinid, Interakcje z innymi lekami)

  • Rufinamidlek przeciwdrgawkowyNiewielka

    Hormonal contraceptives may be less effective with BANZEL; use additional non-hormonal forms of contraception ( 7.3 ) (etykieta leku Rufinamid, Interakcje z innymi lekami)

  • Saksagliptyna + metforminainhibitor DPP-4Niewielka

    These medications include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid. (etykieta leku Saksagliptyna + metformina, Interakcje z innymi lekami)

  • Sytagliptyna + metforminainhibitor DPP-4Niewielka

    Examples: Thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, and isoniazid. (etykieta leku Sytagliptyna + metformina, Interakcje z innymi lekami)

  • Terbinafinalek przeciwgrzybiczyNiewielka

    There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, phenytoins, thiazide diuretics, and calcium channel blockers. (etykieta leku Terbinafina, Interakcje z innymi lekami)

  • Tetracyklinaantybiotyk tetracyklinowyNiewielka

    A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • Tygecyklinaantybiotyk tetracyklinowyNiewielka

    A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (etykieta leku Dioctan etynodiolu + etynyloestradiol, Interakcje z innymi lekami)

  • Zyprazydonlek przeciwpsychotycznyNiewielka

    Oral Contraceptives In vivo studies have revealed no effect of ziprasidone on the pharmacokinetics of estrogen or progesterone components. (etykieta leku Zyprazydon, Interakcje z innymi lekami)

Nie zgłoszono istotnej interakcji (16)

  • Acebutololbeta-blokerBrak interakcji

    No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed. (etykieta leku Acebutolol, Interakcje z innymi lekami)

  • AlosetronBrak interakcji

    Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates). (etykieta leku Alosetron, Interakcje z innymi lekami)

  • Daryfenacynalek przeciwcholinergicznyBrak interakcji

    Combination oral contraceptives Darifenacin (10 mg three times daily) had no effect on the pharmacokinetics of the combination oral contraceptives containing levonorgestrel and ethinyl estradiol [see Clinical Pharmacology (12.3)] . (etykieta leku Daryfenacyna, Interakcje z innymi lekami)

  • Dofetylidlek przeciwarytmicznyBrak interakcji

    Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide. (etykieta leku Dofetylid, Interakcje z innymi lekami)

  • Dorawirynalek przeciwretrowirusowyBrak interakcji

    …clinically significant changes in concentration were observed for the following agents when co-administered with doravirine: dolutegravir, lamivudine, TDF, elbasvir and grazoprevir, ledipasvir and sofosbuvir, atorvastatin, an oral contraceptive containing ethinyl estradiol and levonorgestrel, metformin, methadone, and midazolam [see Clinical Pharmacology (12.3) ] . (etykieta leku Dorawiryna, Interakcje z innymi lekami)

  • Emtrycytabina + rylpiwiryna + tenofowirlek przeciwretrowirusowyBrak interakcji

    No clinically significant drug interactions have been observed between RPV and the following medications: acetaminophen, atorvastatin, chlorzoxazone, ethinyl estradiol, ledipasvir/sofosbuvir, norethindrone, sildenafil, simeprevir, sofosbuvir, sofosbuvir/velpatasvir, sofosbuvir/velpatasvir/voxilaprevir, or TDF. (etykieta leku Emtrycytabina + rylpiwiryna + tenofowir, Interakcje z innymi lekami)

  • Emtrycytabina + tenofowirlek przeciwretrowirusowyBrak interakcji

    No clinically significant drug interactions have been either observed or are expected when DESCOVY is combined with the following drugs: buprenorphine, itraconazole, ketoconazole, lorazepam, methadone, midazolam, naloxone, norbuprenorphine, norgestimate/ethinyl estradiol, and sertraline. (etykieta leku Emtrycytabina + tenofowir, Interakcje z innymi lekami)

  • Fezoterodynalek przeciwcholinergicznyBrak interakcji

    Oral Contraceptives In the presence of fesoterodine, there are no clinically significant changes in the plasma concentrations of combined oral contraceptives containing ethinyl estradiol and levonorgestrel [see Clinical Pharmacology (12.3) ] . (etykieta leku Fezoterodyna, Interakcje z innymi lekami)

  • Ledipaswir + sofosbuwirlek przeciwwirusowyBrak interakcji

    …sofosbuvir is used with the following drugs [see Clinical Pharmacology (12.3) ]: abacavir, atazanavir/ritonavir, cyclosporine, darunavir/ritonavir, dolutegravir, efavirenz, elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide, emtricitabine, lamivudine, methadone, midazolam, oral contraceptives, pravastatin, raltegravir, rilpivirine, tacrolimus, or verapamil. (etykieta leku Ledipaswir + sofosbuwir, Interakcje z innymi lekami)

  • Montelukastantagonista receptora leukotrienowegoBrak interakcji

    No dose adjustment is needed when SINGULAIR is co-administered with theophylline, prednisone, prednisolone, oral contraceptives, fexofenadine, digoxin, warfarin, gemfibrozil, itraconazole, thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines, decongestants, and Cytochrome P450 (CYP) enzyme inducers [see Clinical Pharmacology… (etykieta leku Montelukast, Interakcje z innymi lekami)

  • Raltegrawirlek przeciwretrowirusowyBrak interakcji

    Drugs without Clinically Significant Interactions with ISENTRESS In drug interaction studies, raltegravir did not have a clinically meaningful effect on the pharmacokinetics of the following: hormonal contraceptives, methadone, lamivudine, tenofovir, etravirine, darunavir/ritonavir, or boceprevir. (etykieta leku Raltegrawir, Interakcje z innymi lekami)

  • RyzatryptantryptanBrak interakcji

    Oral contraceptives : In a study of concurrent administration of an oral contraceptive during 6 days of administration of MAXALT (10-30 mg/day) in healthy female volunteers (n=18), rizatriptan did not affect plasma concentrations of ethinyl estradiol or norethindrone. (etykieta leku Ryzatryptan, Interakcje z innymi lekami)

  • Sofosbuwir + welpataswirlek przeciwwirusowyBrak interakcji

    …clinically significant drug interactions have been observed with the following drugs [see Clinical Pharmacology (12.3) ]: VOSEVI: cobicistat, darunavir, elvitegravir, emtricitabine, ethinyl estradiol/norgestimate, gemfibrozil, rilpivirine, ritonavir, tenofovir alafenamide, voriconazole Sofosbuvir/velpatasvir: dolutegravir, ketoconazole, raltegravir Sofosbuvir:… (etykieta leku Sofosbuwir + welpataswir, Interakcje z innymi lekami)

  • Tiagabinalek przeciwdrgawkowyBrak interakcji

    Oral Contraceptives : Multiple dose administration of tiagabine (8 mg/day monotherapy) did not alter the pharmacokinetics of oral contraceptives in healthy women of child-bearing age. (etykieta leku Tiagabina, Interakcje z innymi lekami)

  • Zafirlukastantagonista receptora leukotrienowegoBrak interakcji

    In a single-blind, parallel-group, 3-week study in 39 healthy female subjects taking oral contraceptives, 40 mg twice daily of zafirlukast had no significant effect on ethinyl estradiol plasma concentrations or contraceptive efficacy. (etykieta leku Zafirlukast, Środki ostrożności)

  • Zileutoninhibitor CYP1A2Brak interakcji

    Other Concomitant Drug Therapy Drug-drug interaction studies conducted in healthy subjects between zileuton immediate-release tablets and prednisone and ethinyl estradiol (oral contraceptive), drugs known to be metabolized by the CYP3A4 isoenzyme, have shown no significant interaction. (etykieta leku Zileuton, Interakcje z innymi lekami)

Sprawdź, jak Dioctan etynodiolu + etynyloestradiol łączy się ze wszystkim, co przyjmujesz. Dodaj całą listę; wszystkie pary są sprawdzane jednocześnie.

Otwórz w wyszukiwarce

To nie jest porada medyczna. Stopień nasilenia odzwierciedla sformułowania etykiety, a nie indywidualne okoliczności. Oznaczenie „poważna” może dotyczyć połączenia stosowanego rutynowo pod nadzorem, a „niewielka” może mieć znaczenie przy dużych dawkach. Należy zapytać farmaceutę.